Pfizer CEO says vaccine to combat omicron variant will be ready in March

Published



Pfizer might soon have a new version of its vaccine on the market that targets the omicron variant of COVID-19, which the company expects will be ready in March.

In an interview with CNBC’s Squawk Box on Monday, Pfizer CEO Albert Bourla said the company has already started manufacturing doses of the vaccine.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.